InvestorsHub Logo
icon url

DewDiligence

04/26/18 9:10 AM

#218728 RE: DewDiligence #218726

ABBV raises 2018 HCV sales guidance to $3.5B (from $2.5B). Almost all of this will come from Mavyret (which accounted for $850M of the $919M HCV sales logged during 1Q18).